Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor, Proceedings of the National Academy of Sciences, vol.98, issue.7, pp.4215-4220, 2000. ,
DOI : 10.1073/pnas.071048198
Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene, Neuromuscul Disord, vol.12, pp.151-157, 2003. ,
Workshop report of the 89th ENMC International Workshop: Central Core Disease, 19th???20th January 2001, Hilversum, The Netherlands, Neuromuscular Disorders, vol.12, issue.6, pp.588-595, 2002. ,
DOI : 10.1016/S0960-8966(02)00002-0
Altered Ryanodine Receptor Function in Central Core Disease Leaky or Uncoupled Ca2+ Release Channels?, Trends in Cardiovascular Medicine, vol.12, issue.5, pp.189-197, 2002. ,
DOI : 10.1016/S1050-1738(02)00163-9
Functional Characterization of Mutants in the Predicted Pore Region of the Rabbit Cardiac Muscle Ca2+ Release Channel (Ryanodine Receptor Isoform 2), Journal of Biological Chemistry, vol.276, issue.34, pp.31760-31771, 2001. ,
DOI : 10.1074/jbc.M102751200
Topology of the Ca21 release channel of skeletal muscle sarcoplasmic reticulum (RYR1), 2002. ,
Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes, Biochemical Journal, vol.395, issue.2, pp.259-266, 2006. ,
DOI : 10.1042/BJ20051282
URL : https://hal.archives-ouvertes.fr/inserm-00383898
Interactions between dihydropyridine receptors and ryanodine receptors in striated muscle, Progress in Biophysics and Molecular Biology, vol.79, issue.1-3, pp.45-75, 2002. ,
DOI : 10.1016/S0079-6107(02)00013-5
A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility, Br J Anaesth, vol.56, pp.1267-1269, 1994. ,
Multi-minicore disease-searching for boundaries: Phenotype analysis of 38 cases, Annals of Neurology, vol.52, issue.5, pp.745-757, 2000. ,
DOI : 10.1002/1531-8249(200011)48:5<745::AID-ANA8>3.0.CO;2-F
Mutations of the Selenoprotein N Gene, Which Is Implicated in Rigid Spine Muscular Dystrophy, Cause the Classical Phenotype of Multiminicore Disease: Reassessing the Nosology of Early-Onset Myopathies, The American Journal of Human Genetics, vol.71, issue.4, pp.739-749, 2002. ,
DOI : 10.1086/342719
A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene, Annals of Neurology, vol.276, issue.11, pp.750-759, 2002. ,
DOI : 10.1002/ana.10231
Tissue-specific and developmentally regulated alternative splicing in mouse skeletal muscle ryanodine receptor mRNA, Biochemical Journal, vol.305, issue.2, pp.373-378, 1995. ,
DOI : 10.1042/bj3050373
Frequency and localization of mutations in the 106 exons of theRYR1 gene in 50 individuals with malignant hyperthermia, Human Mutation, vol.27, issue.8, p.830, 2006. ,
DOI : 10.1002/humu.9442
The highways and byways of mRNA decay, Nature Reviews Molecular Cell Biology, vol.127, issue.2, pp.113-126, 2007. ,
DOI : 10.1038/nrm2104
Congenital Myopathies in the New Millennium, Journal of Child Neurology, vol.14, issue.2, pp.94-101, 2005. ,
DOI : 10.1177/08830738050200020201
Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores, Neurology, vol.59, issue.2, pp.284-287, 2002. ,
DOI : 10.1212/WNL.59.2.284
Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene, Neurology, vol.65, issue.12, pp.1930-1935, 2005. ,
DOI : 10.1212/01.wnl.0000188870.37076.f2
Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1, Human Molecular Genetics, vol.14, issue.15, pp.2189-2200, 2005. ,
DOI : 10.1093/hmg/ddi223
A variably spliced region in the type 1 ryanodine receptor may participate in an inter-domain interaction, Biochemical Journal, vol.401, issue.1, pp.317-324, 2007. ,
DOI : 10.1042/BJ20060686
Central core disease due to recessive mutations inRYR1 gene: Is it more common than described?, Muscle & Nerve, vol.265, issue.5, pp.670-674, 2007. ,
DOI : 10.1002/mus.20715
Negatively Charged Amino Acids within the Intraluminal Loop of Ryanodine Receptor Are Involved in the Interaction with Triadin, Journal of Biological Chemistry, vol.279, issue.8, pp.6994-7000, 2004. ,
DOI : 10.1074/jbc.M312446200
A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease, Proceedings of the National Academy of Sciences, vol.96, issue.7, pp.4164-4169, 1999. ,
DOI : 10.1073/pnas.96.7.4164
Cloning and Characterization of a New Isoform of Skeletal Muscle Triadin, Journal of Biological Chemistry, vol.275, issue.11, pp.8206-8212, 1994. ,
DOI : 10.1074/jbc.275.11.8206
An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor, Human Molecular Genetics, vol.9, issue.18, pp.2599-2608, 2000. ,
DOI : 10.1093/hmg/9.18.2599
Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor, Human Molecular Genetics, vol.10, issue.22, pp.2581-2592, 2001. ,
DOI : 10.1093/hmg/10.22.2581
A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with MmD congenital myopathy with ophthalmoplegia, Hum Mol Genet, vol.12, pp.1-8, 2003. ,
Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility, Human Mutation, vol.274, issue.5, pp.413-425, 2005. ,
DOI : 10.1002/humu.20231
URL : https://hal.archives-ouvertes.fr/inserm-00388722
in malignant hyperthermia and central core disease, Human Mutation, vol.12, issue.10, pp.977-989, 2006. ,
DOI : 10.1002/humu.20356
Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia, Brain, vol.126, issue.11, pp.2341-2349, 2003. ,
DOI : 10.1093/brain/awg244
A NEW CONGENITAL NON-PROGRESSIVE MYOPATHY, Brain, vol.79, issue.4, pp.610-621, 1956. ,
DOI : 10.1093/brain/79.4.610
Central core disease is due to RYR1 mutations in more than 90% of patients, Brain, vol.129, issue.6, pp.1470-1480, 2006. ,
DOI : 10.1093/brain/awl077
Epigenetic Allele Silencing Unveils Recessive RYR1 Mutations in Core Myopathies, The American Journal of Human Genetics, vol.79, issue.5, pp.859-868, 2006. ,
DOI : 10.1086/508500
Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies, Brain, vol.130, issue.8, pp.2024-2036, 2007. ,
DOI : 10.1093/brain/awm096